News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
684,604 Results
Type
Article (39059)
Company Profile (284)
Press Release (645261)
Section
Business (204032)
Career Advice (1991)
Deals (35383)
Drug Delivery (84)
Drug Development (80861)
Employer Resources (168)
FDA (16091)
Job Trends (14816)
News (344794)
Policy (32452)
Tag
Academia (2531)
Alliances (49112)
Alzheimer's disease (1217)
Approvals (16010)
Artificial intelligence (122)
Bankruptcy (352)
Best Places to Work (11494)
Biotechnology (203)
Breast cancer (109)
Cancer (966)
Cardiovascular disease (82)
Career advice (1659)
Cell therapy (210)
Clinical research (64051)
Collaboration (340)
Compensation (173)
COVID-19 (2529)
C-suite (85)
Data (941)
Diabetes (139)
Diagnostics (6116)
Earnings (84491)
Employer resources (146)
Events (109231)
Executive appointments (255)
FDA (16554)
Funding (299)
Gene therapy (155)
GLP-1 (565)
Government (4319)
Healthcare (18675)
Infectious disease (2607)
Inflammatory bowel disease (103)
Interviews (309)
IPO (16285)
Job creations (3632)
Job search strategy (1417)
Layoffs (409)
Legal (7850)
Lung cancer (158)
Manufacturing (157)
Medical device (13154)
Medtech (13159)
Mergers & acquisitions (19133)
Metabolic disorders (374)
Neuroscience (1461)
NextGen Class of 2024 (6508)
Non-profit (4464)
Northern California (1304)
Obesity (222)
Opinion (176)
Patents (96)
People (56231)
Phase I (19891)
Phase II (28205)
Phase III (21044)
Pipeline (319)
Postmarket research (2554)
Preclinical (8464)
Radiopharmaceuticals (234)
Rare diseases (190)
Real estate (5901)
Regulatory (21478)
Research institute (2308)
Resumes & cover letters (350)
Southern California (1162)
Startups (3567)
United States (12259)
Vaccines (541)
Weight loss (162)
Date
Today (294)
Last 7 days (1028)
Last 30 days (3294)
Last 365 days (35736)
2024 (31135)
2023 (40102)
2022 (51230)
2021 (55764)
2020 (54127)
2019 (46568)
2018 (35042)
2017 (32144)
2016 (31522)
2015 (37590)
2014 (31361)
2013 (26382)
2012 (28585)
2011 (29284)
2010 (27353)
Location
Africa (713)
Arizona (188)
Asia (37114)
Australia (6062)
California (2933)
Canada (1202)
China (222)
Colorado (128)
Connecticut (130)
Europe (79440)
Florida (413)
Georgia (104)
Illinois (315)
Indiana (186)
Kansas (96)
Maryland (545)
Massachusetts (2365)
Michigan (145)
Minnesota (259)
New Jersey (863)
New York (873)
North Carolina (676)
Northern California (1304)
Ohio (129)
Pennsylvania (783)
South America (1091)
Southern California (1162)
Texas (402)
Utah (84)
Washington State (333)
684,604 Results for "latigo biotherapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Latigo Biotherapeutics Doses First Participant in Phase 1 Clinical Trial of LTG-305 for Non-Opioid Treatment of Pain
October 17, 2024
·
3 min read
Biotech Beach
Latigo Biotherapeutics Debuts with $135 Million Series A Financing to Develop Non-Opioid Pain Medicines
Latigo Biotherapeutics Inc., a clinical-stage biotechnology company developing best-in-class non-opioid pain medicines that target pain at its source, announced its emergence from stealth with a $135 million Series A financing.
February 14, 2024
·
3 min read
Press Releases
Latigo Biotherapeutics Appoints Tim Lugo as Chief Financial Officer and Adds Beth Seidenberg and Jim Tananbaum to Board of Directors
September 9, 2024
·
6 min read
Press Releases
Latigo Biotherapeutics Appoints Nima Farzan as Chief Executive Officer, Positioning Company for Rapid Growth
July 22, 2024
·
3 min read
Press Releases
Latigo Biotherapeutics Announces Positive Phase 1 Data for Lead Non-Opioid Pain Medicine Candidate and Appoints Neil Singla, M.D., Chief Medical Officer
August 19, 2024
·
5 min read
Latigo Launches into Non-Opioid Pain Medicine Space with $135 Million Series A
Two weeks after Vertex’s Phase III data for VX-548 reenergized the field, Latigo Biotherapeutics announced $135 million in Series A funds to push its own NaV1.8 inhibitor into Phase II.
February 13, 2024
·
3 min read
·
Heather McKenzie
Press Releases
Sonnet BioTherapeutics Inc. Regains Compliance with Nasdaq
October 18, 2024
·
4 min read
Business
Mid-Atlantic BioTherapeutics, Inc. and SMITM Capital Markets Ltd enter into a significant financing agreement
SMITM CAPITAL MARKETS LTD, has announced a significant agreement with Mid-Atlantic BioTherapeutics, Inc. (MABT), a clinical-stage ready US biopharmaceutical company.
June 19, 2024
·
4 min read
Press Releases
NYSE American to Commence Delisting Proceedings with Respect to the Warrants of Calidi Biotherapeutics, Inc. (CLDI WS)
October 21, 2024
·
3 min read
Deals
Calidi Biotherapeutics, Inc. Announces Pricing of $6.1 Million Public Offering
Calidi Biotherapeutics, Inc. today announced the pricing of its “reasonable best efforts” public offering of 15,197,500 shares of common stock (or pre-funded warrants in lieu thereof) and accompanying Series A Common Warrants.
April 16, 2024
·
5 min read
1 of 68,461
Next
